ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Litfulo 50 mg, Hartkapseln - 30
69695001 Pfizer AG
Litfulo 50 mg, Hartkapseln03.02.2025
  03.02.2025
(L04AF08) 
WHO-DDD02.02.2030
30
07.15. 
B  
No 
IPCI
PR  
k.A.PR
  
7680696950013Synthetika
  
Composition
ritlecitinibum 50 mg ut ritlecitinibi tosilas, cellulosum microcristallinum, lactosum monohydricum 21.269 mg, crospovidonum, glyceroli dibehenas, Kapselhülle: hypromellosum, E 171, E 172 (flavum), E 133, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 172 (nigrum), kalii hydroxidum, pro capsula.
Packungsbestandteile
Capsules
 
Active AgentDose
Ritlecitinibum50 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
Ammoniae Solutio Concentrata  
Cellulosum Microcristallinum  
Crospovidonum  
E 133 color.
E 171 color.
E 172 color.
Glyceroli Dibehenas  
Hypromellosum Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Lactose Monohydrate21.269 mg 
Pro Capsula  
Propylenglycol  
Source
Data was imported : 12.03.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home